How much funding has ClearNote Health raised?

ClearNote Health has disclosed $143.1M raised across 3 rounds.

Where is ClearNote Health headquartered?

ClearNote Health is headquartered in San Diego, US.

ClearNote Health

San Diego, US · Founded 2016 · Delaware corporation · 1 known investors

Find your way into ClearNote Health

308 people in our graph share verified history with the ClearNote Health team — schools, employers, funds. One of them is your warm intro.

Ramin Khaksarunlockedknows Samuel Levy · together at Clear Labs (overlapped)

knows the team · via Clear Labs

×5knows the team · via Alere Inc.

knows the team · via Hologic

×4knows the team · via Exelixis

ClearNote Health develops DNA-based blood tests (the Avantect line for pancreatic, ovarian, and multi-cancer detection) aimed at detecting cancer at early stages in patients at elevated risk. It also offers Virtuoso, an epigenomics platform that measures disease biology and therapy response from a blood draw for drug discovery and development.

Biotech Digital Health Healthtech

Founders & leadership

David MullarkeyExecutive

Samuel Levy Chief Executive OfficerSamuel Levy brings nearly 30 years of experience in healthcare, biotechnology, life sciences, genomics, and clinical diagnostics, with a background in business development and general management across cross-functional teams. He serves as Executive Officer of ClearNote Health, which develops DNA-based blood tests for early cancer detection and an epigenomics platform for drug discovery.

Johan Mattias WestermanNamed on SEC filing

Board

Johan Mattias WestmanBoard director

Tina NovaBoard director

Stephen QuakeBoard director

Investors · 1

Also in the syndicate · 1

Mattias Westmanlead

Funding

SEC filings, press & company announcements

$143.1M disclosed across 3 rounds · 2019–2026

$52MSeries DMay 2026 · 4 sources
Mattias Westman (lead)
Source ↗

▶$21.8MraisedJun 2025 · 5 investors · Biotechnology

Rule 506(b)

Officers, directors & promoters on the filing

Tina NovaDirector
David MullarkeyExecutive Officer, Director
Samuel LevyExecutive Officer
Johan Mattias WestmanDirector
Stephen QuakeDirector

Offering amount: $60.5M
Amount sold: $21.8M
First sale: May 2025
Incorporated: Corporation, Delaware
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

▶$69.3MraisedJun 2021 · 14 investors · Biotechnology

Rule 506(b)

Officers, directors & promoters on the filing

Stephen QuakeDirector
Tina NovaDirector
Johan Mattias WestermanDirector
Samuel LevyExecutive Officer

Offering amount: $71.6M
Amount sold: $69.3M
First sale: Mar 2019
Incorporated: Corporation, Delaware, 2016
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Competitors · 5

by search overlap

Topera16 shared keywordsAbbott's Lingo Glucose System is a continuous glucose monitoring device for non-insulin users aged 18+, designed to track glucose levels and support metabolic health decisions.

Labcorp13 shared keywordsLabCorp provides diagnostic testing services and clinical trial recruitment solutions that connect patient insights to drug development for healthcare providers.

Guardant Health12 shared keywordsGuardant Health develops blood-based testing (liquid biopsy) for cancer detection and monitoring across all stages of the disease. The company serves oncologists, patients, and biopharmaceutical firms with FDA-approved tests for cancer screening, early-stage risk assessment, and treatment selection.

Exact Sciences12 shared keywordsExact Sciences develops molecular diagnostic tests for cancer screening and detection, including multitarget stool DNA testing for colorectal cancer and multigene assays for breast cancer recurrence. The company serves patients and healthcare providers in the cancer diagnostics field.

American Cancer Society (ACS)10 shared keywordsThe American Cancer Society is a nonprofit organization that provides cancer research updates, screening and prevention guidance, and community engagement opportunities. It serves individuals seeking cancer information and those who want to support cancer research and patient advocacy efforts.

Companies competing with ClearNote Health for the same Google search keywords, organic and paid, via search-intersection analysis.

Frequently asked questions

What does ClearNote Health do?: ClearNote Health develops DNA-based blood tests (the Avantect line for pancreatic, ovarian, and multi-cancer detection) aimed at detecting cancer at early stages in patients at elevated risk. It also offers Virtuoso, an epigenomics platform that measures disease biology and therapy response from a blood draw for drug discovery and development.
How much funding has ClearNote Health raised?: ClearNote Health has disclosed $143.1M raised across 3 rounds.
Where is ClearNote Health headquartered?: ClearNote Health is headquartered in San Diego, US.